美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPDR S&P Biotech ETF

157.60

+1.400.90%

盤後：157.700.1000+0.06%19:55 EDT

成交量：618.42萬

成交額：9.74億

市值：104.65億

市盈率：8.65

高：158.97

開：156.86

低：156.20

收：156.20

52周最高：169.89

52周最低：92.64

股本：6,640.00萬

流通股本：6,640.00萬

量比：0.86

換手率：9.31%

股息：0.58

股息率：0.37%

每股收益(TTM):18.23

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

醫療保健板塊市場快訊

醫療健康板塊綜述：市場動態快報

人保健康天津分公司因欺騙投保人被罰28萬元一人被終身禁業

胡偉獲批擔任人保健康董事

和諧健康保險孝感中支被罰18萬，涉編制虛假資料

醫療保健板塊市場快訊匯總

非阿片止痛藥開發商Latigo(LTGO.US)欲乘生物科技IPO「東風」！發行定價18美元/股擬籌資3.46億美元

北京經濟技術開發區：鼓勵具身智能、自動駕駛、醫療健康等重點領域數據交易流通每年發放1億元數據券

從8000元降價到200元！福建山區小縣登上人民日報

百餘家上市公司發布2026年半年報生物醫藥等行業現亮點

百餘家上市公司發布2026年半年報生物醫藥等行業現亮點

宜明昂科-B(01541)附屬宜明凱爾生物醫藥技術(上海)獲增資5000萬元

宜明昂科-B(01541.HK)附屬宜明凱爾生物醫藥技術(上海)獲增資5000萬元

醫療保健板塊市場動態綜述

生物科技IPO熱潮持續!心血管藥企Braveheart(BRVE.US)募資擴大至3.825億美元，發行價突破指引上限

醫療板塊市場動態速覽

海關試點跨關區協同監管新模式

东北新闻网

構建社保商保分層協同機制，破解創新藥支付困境——商業醫療保險與創新藥支付管理研討會在京召開

生物科技公司Braveheart在美國IPO中籌集3.825億美元。

上海國投先導、恩華藥業等在上海成立創投基金

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/XBI/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":157.6,"timestamp":1789416000000,"preClose":156.2,"halted":0,"volume":6184224,"hourTrading":{"tag":"盘后","latestPrice":157.7,"preClose":157.6,"latestTime":"19:55 EDT","volume":537837,"amount":84762920.045,"timestamp":1789430106263,"change":0.1,"changeRate":0.000635,"amplitude":0.004886},"delay":0,"changeRate":0.008962868117797732,"floatShares":66400000,"shares":66400000,"eps":18.23,"marketStatus":"已收盤","change":1.4,"latestTime":"09-14 16:00:00 EDT","open":156.86,"high":158.965,"low":156.2,"amount":974172668.5008,"amplitude":0.017702,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.2,"sharesOutstanding":63325000,"nav":156.174274,"aum":10736981366.38,"dividendRate":0.003667,"bidAskSpread":0.000302,"preHourTrading":{"tag":"盘前","latestPrice":156.74,"preClose":156.2,"latestTime":"09:29 EDT","volume":20285,"amount":3166840.2419000003,"timestamp":1789392599999,"change":0.54,"changeRate":0.003457,"amplitude":0.012285},"postHourTrading":{"tag":"盘后","latestPrice":157.7,"preClose":157.6,"latestTime":"19:55 EDT","volume":537837,"amount":84762920.045,"timestamp":1789430106263,"change":0.1,"changeRate":0.000635,"amplitude":0.004886},"volumeRatio":0.860408,"impliedVol":0.3059,"impliedVolPercentile":0.4422},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":66400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.860408,"shares":66400000,"dividePrice":0.5779,"high":158.965,"amplitude":0.017702,"preClose":156.2,"low":156.2,"week52Low":92.64,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":157.6,"eps":18.23,"divideRate":0.003667,"volume":6184224,"delay":0,"ttmEps":18.23,"open":156.86,"prevYearClose":121.93,"prevWeekClose":156.2,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":163.81,"twentyDayClose":157.41,"sixtyDayClose":139.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1183021512","title":"醫療保健板塊市場快訊","url":"https://stock-news.laohu8.com/highlight/detail?id=1183021512","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183021512?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 04:55","pubTimestamp":1786136134,"startTime":"0","endTime":"0","summary":"她认为该交易按当前方案完成的可能性为75%，但鉴于Jamieson的“优质资产”属性、在加拿大的领先市场份额，以及预计至2028年收入复合年增长率达11%，存在25%的可能性出现更高报价。消息公布后，TD将目标股价从48加元上调至49加元，以反映概率加权结果，但将评级从“买入”下调至“持有”。该股盘中上涨9.6%，报45.47加元。** 欧洲斯托克600指数上涨0.2%，软件和医疗保健板块领涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4581","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145080185","title":"醫療健康板塊綜述：市場動態快報","url":"https://stock-news.laohu8.com/highlight/detail?id=1145080185","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145080185?lang=zh_tw&edition=fundamental","pubTime":"2026-08-08 00:23","pubTimestamp":1786119809,"startTime":"0","endTime":"0","summary":"她在报告中坦言，“对报价未达预期感到惊讶”。该分析师认为，按当前方案完成交易的概率为75%，但同时存在25%的可能性，因Jamieson具备“优质资产”属性、在加拿大市场占据领先份额，且预计至2028年收入复合年增长率达11%，报价有望被上调。消息公布后，TD将目标股价从48加元上调至49加元，以反映概率加权结果，同时将评级从“买入”下调至“持有”。该股现涨9.6%，报45.47加元。泛欧斯托克600指数上涨0.2%，软件与医疗健康板块领涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4588","XLV","BK4581","XBI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657649773","title":"人保健康天津分公司因欺騙投保人被罰28萬元 一人被終身禁業","url":"https://stock-news.laohu8.com/highlight/detail?id=2657649773","media":"金融一线","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657649773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 21:36","pubTimestamp":1786109760,"startTime":"0","endTime":"0","summary":"8月7日金融一线消息，国家金融监督管理总局天津监管局行政处罚信息公开表显示，中国人民健康保险股份有限公司天津分公司因欺骗投保人，被罚款28万元。闻伟被禁止终身进入保险业。序号当事人名称主要违法违规行为行政处罚内容作出决定机关1中国人民健康保险股份有限公司天津分公司欺骗投保人。对中国人民健康保险股份有限公司天津分公司罚款28万元；对闻伟禁止终身进入保险业国家金融监督管理总局天津监管局","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/fd/2026-08-07/doc-inimnzse9955329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","XBI","XLV","LABU","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657643444","title":"胡偉獲批擔任人保健康董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2657643444","media":"金融一线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657643444?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 20:09","pubTimestamp":1786104540,"startTime":"0","endTime":"0","summary":"8月7日金融一线消息，国家金融监督管理总局发布《关于胡伟中国人民健康保险股份有限公司董事任职资格的批复》，核准胡伟中国人民健康保险股份有限公司董事的任职资格。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jryx/hm/2026-08-07/doc-inimnzsm4704005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","XBI","BK4585","BK4581","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657617229","title":"和諧健康保險孝感中支被罰18萬，涉編制虛假資料","url":"https://stock-news.laohu8.com/highlight/detail?id=2657617229","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657617229?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 18:58","pubTimestamp":1786100322,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月7日讯，近日，孝感金融监管分局发布行政处罚决定书，剑指和谐健康保险股份有限公司孝感中心支公司及相关责任人。罚单显示，和谐健康保险股份有限公司孝感中心支公司的主要违法违规行为是：编制虚假资料。针对上述违法行为，孝感金融监管分局对和谐健康保险股份有限公司孝感中心支公司罚款18万元，对李婷警告并罚款2.5万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1786096518804106658","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LABU","BK4581","XLV","XBI","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129560773","title":"醫療保健板塊市場快訊匯總","url":"https://stock-news.laohu8.com/highlight/detail?id=1129560773","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129560773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 16:22","pubTimestamp":1786090970,"startTime":"0","endTime":"0","summary":"投资者在美国就业数据和中东局势谈判消息出炉前保持观望态度。泛欧斯托克600指数微涨0.2%，软件与医疗保健板块领涨。伦敦富时100指数同样小幅上扬0.2%，国际油价企稳带动石油巨头走强。帝亚吉欧延续涨势，股价已连续第二个交易日攀升，目前涨幅达1.5%。软件巨头SAP攀升3.5%，但戴姆勒卡车控股公司在发布财报后下跌2.9%。意大利富时MIB指数基本持平，而西班牙IBEX 35指数因银行股走弱而微跌0.3%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","BK4588","BK4581","XLV","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657361568","title":"非阿片止痛藥開發商Latigo(LTGO.US)欲乘生物科技IPO「東風」！發行定價18美元/股 擬籌資3.46億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657361568","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657361568?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 16:20","pubTimestamp":1786090842,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4127","GDOC","MEDX","SYNB","UDN","IPOS","BK4585","FRHC","LNGR","UUP","BK4581","KCE","IBBJ","AGNG","REDS","IEIH","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657965566","title":"北京經濟技術開發區：鼓勵具身智能、自動駕駛、醫療健康等重點領域數據交易流通 每年發放1億元數據券","url":"https://stock-news.laohu8.com/highlight/detail?id=2657965566","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657965566?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 12:34","pubTimestamp":1786077245,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4550","TARK","IXJ","HAIL","XT","KOMP","MOTO","BK4585","VHT","XBI","FAI","CARZ","IDRV","BK4581","LABU","NBDS","FDIF","XLV","BK4588","DRIV","WDRN","ROBT","IQM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657466712","title":"從8000元降價到200元！福建山區小縣登上人民日報","url":"https://stock-news.laohu8.com/highlight/detail?id=2657466712","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657466712?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 09:04","pubTimestamp":1786064640,"startTime":"0","endTime":"0","summary":"8月6日，人民日报刊发《延伸链条，老区“长”出新产业》一文，关注福建明溪。“从红豆杉里提取的紫杉醇是抗肿瘤药的有效成分。上世纪末，由于要从树皮里提取，一支制剂能卖到8000元，一公斤原料药值300万元。”随着成本大幅下降，每支紫杉醇制剂价格降到200元。市民在选购进口产品。据了解，明溪县已培育近50家侨资企业，吸引项目投资超20亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-07/doc-inimmyet0104916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657360664","title":"百餘家上市公司發布2026年半年報 生物醫藥等行業現亮點","url":"https://stock-news.laohu8.com/highlight/detail?id=2657360664","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657360664?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 07:36","pubTimestamp":1786059397,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4581","161726","XBI","399441","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661078","title":"百餘家上市公司發布2026年半年報 生物醫藥等行業現亮點","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661078","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661078?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 07:25","pubTimestamp":1786058703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","XBI","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657661971","title":"宜明昂科-B(01541)附屬宜明凱爾生物醫藥技術(上海)獲增資5000萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657661971","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657661971?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 06:57","pubTimestamp":1786057046,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宜明昂科-B 发布公告，于2026年8月6日，本公司、宜明凯尔生物医药技术(上海)有限公司、嘉兴张科领弋生科起航创业投资合伙企业、苏州新界创元企业管理合伙企业及王雪岩先生订立增资协议。根据增资协议，投资者同意以总对价人民币5000万元认缴合共人民币46.5万元经扩大注册资本，约占目标公司经扩大股权的15.83%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477063.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["161726","BK4588","399441","BK4585","BK4581","BK1161","XBI","01541"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657619746","title":"宜明昂科-B(01541.HK)附屬宜明凱爾生物醫藥技術(上海)獲增資5000萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2657619746","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657619746?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 06:57","pubTimestamp":1786057046,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160721676","title":"醫療保健板塊市場動態綜述","url":"https://stock-news.laohu8.com/highlight/detail?id=1160721676","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160721676?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 00:25","pubTimestamp":1786033543,"startTime":"0","endTime":"0","summary":"0739 ET - 伦敦上市制药商Hikma Pharmaceuticals上半年业绩表现强劲，但其对全年业绩的展望却显得颇为保守，并未随之上调，这令市场感到意外。这一积极表现主要得益于Hikma旗下品牌药部门的强劲增长，预计将受到投资者的欢迎。然而，即便上半年核心运营利润率大幅改善，Hikma仍坚持其2026年全年核心运营利润指引，即7.2亿至7.7亿美元，这一区间与市场普遍预期的7.31亿美元相比，并未显得更为乐观。受此消息影响，公司股价大涨10%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4581","LABU","XBI","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657070685","title":"生物科技IPO熱潮持續!心血管藥企Braveheart(BRVE.US)募資擴大至3.825億美元，發行價突破指引上限","url":"https://stock-news.laohu8.com/highlight/detail?id=2657070685","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657070685?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 16:28","pubTimestamp":1786004901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["REDS","AGNG","LNGR","FRHC","KCE","BRVE","BK4581","IEIH","BK4127","GDOC","MEDX","SYNB","XBI","IBBJ","BK4585","IPOS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137064261","title":"醫療板塊市場動態速覽","url":"https://stock-news.laohu8.com/highlight/detail?id=1137064261","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137064261?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 16:26","pubTimestamp":1786004808,"startTime":"0","endTime":"0","summary":"1655 GMT - 礼来公司CEO David Ricks在CNBC上表示，该公司近期推出的每日一次GLP-1口服药Foundayo，尽管定价更低，但正在扩大市场而非蚕食现有市场。与此同时，减肥治疗的覆盖面持续扩大，进一步拓宽了潜在市场总规模。这些利好因素增强了礼来公司的信心，使其将营收预期从820亿至850亿美元上调至850亿至870亿美元。礼来股价目前上涨3%。市场对GLP-1减肥药的持续强劲需求推动第二季度营收跃升48%，达到229.7亿美元，超出预期的206.9亿美元。诺和诺德股价下跌4%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LABU","XBI","BK4581","XLV","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657688495","title":"海關試點跨關區協同監管新模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2657688495","media":"东北新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657688495?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 15:12","pubTimestamp":1786000320,"startTime":"0","endTime":"0","summary":"为落实长三角一体化高质量发展重大战略部署，长三角区域海关协同推出进境动物源性生物材料联合监管试点，创新打造跨关区协同监管新模式，允许二级风险进境动物源性生物材料在同一集团、同等生物安全等级实验室间跨省市流转，一票通关、分段监管，由调出、调入海关分段实施闭环监管，从制度层面破除跨区域监管壁垒，充分释放生物医药创新要素流通活力。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-06/doc-inimkfvc3038063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4581","BK4585","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657669688","title":"構建社保商保分層協同機制，破解創新藥支付困境——商業醫療保險與創新藥支付管理研討會在京召開","url":"https://stock-news.laohu8.com/highlight/detail?id=2657669688","media":"金融一线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657669688?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 14:55","pubTimestamp":1785999300,"startTime":"0","endTime":"0","summary":"专题：新浪健康保险研究院2026年7月31日，由中央财经大学保险学院主办、新浪健康保险研究院协办的“商业医疗保险与创新药支付管理研讨会”在京举行。因此，在医保基金收支承压、商业保险资金池有限、天价药风险集中的现实约束下，造成创新药支付困境凸显。商保在创新药上市早期的支付补充价值。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/bxyy/2026-08-06/doc-inimkfvm3890828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["XLV","BK4585","XBI","06978","LNGR","159992","BK4588","BK1574","BK1161","IBBQ","LABU","MEDX","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657053195","title":"生物科技公司Braveheart在美國IPO中籌集3.825億美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2657053195","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657053195?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 10:47","pubTimestamp":1785984423,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IEIH","BK4581","SMDX","ASCE","LNGR","SYNB","BK4585","AGNG","GDOC","TMSL","XBI","BK4588","IBBJ","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657055503","title":"上海國投先導、恩華藥業等在上海成立創投基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2657055503","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657055503?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 10:36","pubTimestamp":1785983777,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}